Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons...
Vous n'êtes pas connecté
TUESDAY, Sept. 3, 2024 -- Treatment with semaglutide does not increase the risk for developing symptoms of depression or suicidal ideation/behavior among adults with overweight or obesity, according to a study published online Sept. 3 in JAMA...
Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons...
Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons...
Semaglutide, a medlinkweight loss/medlink medication, did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior....
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...
Semaglutide's safety for mental health with FDA evaluations shows no increased risk of depression or suicidal thoughts.
Semaglutide's safety for mental health with FDA evaluations shows no increased risk of depression or suicidal thoughts.
FRIDAY, Sept. 6, 2024 -- The risk for lung cancer is high in patients with rheumatoid arthritis (RA) and pulmonary complications, according to a study...
Highlights: Semaglutide drugs linked to a higher risk of suicidal thoughts, especially with psychiatric medications
FRIDAY, Sept. 13, 2024 -- For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication...